ZILBRYSQ ZILUCOPLAN - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
88918443
Word Mark
ZILBRYSQ ZILUCOPLAN
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2021-06-28
Filing Date
2020-05-15
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2020-09-29
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
CARROLL, DORITT
Statements
Indication of Colors claimed
The colors gray, blue, orange, and red are claimed as features of the mark.
Disclaimer with Predetermined Text
"ZILUCOPLAN"
Description of Mark
The mark consists of the word "ZILUCOPLAN" in gray under the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q".
Goods and Services
Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan
Goods and Services
Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication
Translation of Words in Mark
The wording "ZILBRYSQ ZILUCOPLAN" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-05-30
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2020-05-30
Primary Code
010
Correspondences
Name
Jennifer Bryan
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-05-19 | NEW APPLICATION ENTERED IN TRAM |
2020-05-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-06-18 | ASSIGNED TO EXAMINER |
2020-06-18 | EXAMINERS AMENDMENT -WRITTEN |
2020-06-18 | EXAMINERS AMENDMENT E-MAILED |
2020-06-18 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-06-18 | EXAMINER'S AMENDMENT ENTERED |
2020-06-18 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-06-22 | ASSIGNED TO LIE |
2020-07-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-07-08 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
2020-07-22 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2020-07-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-08-04 | EXAMINERS AMENDMENT -WRITTEN |
2020-08-04 | EXAMINERS AMENDMENT E-MAILED |
2020-08-04 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-08-04 | EXAMINER'S AMENDMENT ENTERED |
2020-08-04 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-08-19 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-08-19 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
2020-08-24 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
2020-08-25 | EXAMINERS AMENDMENT -WRITTEN |
2020-08-25 | EXAMINERS AMENDMENT E-MAILED |
2020-08-25 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2020-08-25 | EXAMINER'S AMENDMENT ENTERED |
2020-08-25 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-09-01 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2020-09-01 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-09-01 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-09-08 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-09-09 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-09-29 | PUBLISHED FOR OPPOSITION |
2020-09-29 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-11-24 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-06-28 | ABANDONMENT - NO USE STATEMENT FILED |
2021-06-28 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |